Keep pulling the thread on Max Hodak.
Science announced that more than 40 people have received its first brain-computer interface (BCI) treatments designed to restore sight.
Science completed a large clinical trial for its retinal implant in the previous year, with results published in the New England Journal of Medicine.
Science is submitting its retinal implant for market approval and expects to receive it later in the current year.
A pair of conjoined twins in Canada, connected by a biological cable between their thalami, can share meaningful elements of their conscious experience, including seeing through each other's eyes to some degree.
Max Hodak predicts that within the next 10 years, retinal prosthetics will be able to achieve near-native acuity, comparable to 20/20 vision, with color and a full field of view.
Science has developed a state-of-the-art optogenetic gene therapy and published a paper on the world's most sensitive optogenetic proteins, which are responsive to indoor office lighting.
Science's bio-hybrid neural interface involves seeding an implant with living, heavily engineered, hypoimmunogenic stem cell-derived neurons that are designed to be hidden from the patient's immune system.
Elon Musk's primary motivation for starting Neuralink was to ensure humanity could merge with AI to avoid being left behind or dominated by superintelligence.
Max Hodak believes it is very possible that the first people who will live to be 1,000 years old are alive today.
Max Hodak believes the field of brain-computer interfaces (BCI) will evolve into a category of many companies and products, similar to the pharmaceutical industry, rather than being dominated by a single BCI device.
Science's retinal implant is a 2x2 millimeter silicon chip with an array of solar panels that is implanted under the retina.
The clinical trial for Science's retinal implant was conducted across 17 sites in Europe.